Regenerative medicine company, Regeneus Ltd (ASX:RGS), today announced plans to open the HiQCell Regenerative Medicine Clinic in Singapore, and the appointment of leading specialist sports physician, Dr Patrick Goh, as Medical Director.
Regenerative medicine company, Regeneus (ASX:RGS) today announced that it had officially launched its Kvax canine cancer treatment within the Australian veterinary market.
Regeneus Ltd (ASX:RGS) is pleased to announce that it has successfully achieved its target of raising A$3m through its Share Purchase Plan offered to shareholders. This now completes the second part of the company's A$6m raising announced to the market on 8 August 2014.
Regeneus Ltd (ASX:RGS) announced today that the Australian Football League (AFL) has granted caseby-case approval for the use of its innovative stem cell therapy, HiQCell(R) as a treatment option for injured AFL players, typically including impact related osteoarthritis and tendonitis.
Australian IVF-focussed company Reproductive Health Science Ltd (ASX:RHS) is pleased to advise Managing Director and CEO Dr Michelle Fraser has launched its lead product, EmbryoCellect(TM) at an international forum for reproductive medicine and embryology in Munich, Germany.
Regenerative medicine company Avita Medical Ltd (ASX:AVH) (OTCMKTS:AVMXY) is pleased to welcome incoming Chairman, Lou Panaccio, who today has formally commenced his role.
SomnoMed Limited (ASX:SOM) (OTCMKTS:SOMNF) announced today its results for the first half year to December 2013. The company posted strong unit and revenue growth, generated profits and cash whilst continuing to invest in its future through its medical initiative and further acquisitions in both Europe and the APAC regions.
